Activated protein C, severe sepsis and 28-day mortality.


Autoria(s): Torre-Prados, M de la; García-de la Torre, A; Nieto-González, M; Lucena-González, I; Escobar-Conesa, R; García-Alcántara, A; Enguix-Armada, A
Data(s)

01/04/2013

01/04/2013

20/05/2012

Resumo

Protein C (PC) de ciency is prevalent in severe sepsis, studies showing that more than 80% of patients with severe sepsis have a baseline PC level below the lower limit of normal [1,2]. The aim of the study was to relate the anticoagulation activity evaluated by PC, with clinical parameters and 28-day mortality.

Identificador

Torre-Prados M de la., García-de la Torre A., Nieto-González M., Lucena-González I., Escobar-Conesa R., García-Alcántara A. et al. Activated protein C, severe sepsis and 28-day mortality. Critical Care. 2012;16(Suppl. 1):S8-S9

1364-8535 (Print)

1466-609X (Online)

http://hdl.handle.net/10668/866

10.1186/cc10630

Idioma(s)

en

Publicador

BioMed Central

Relação

Critical Care

http://ccforum.com/content/16/S1/P23

Direitos

Acceso abierto

Palavras-Chave #Deficiencia de Proteína C #Coagulación Sanguínea #Choque Séptico #Proteina C #Humanos #Medical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Blood Coagulation Disorders::Blood Coagulation Disorders, Inherited::Protein C Deficiency #Medical Subject Headings::Phenomena and Processes::Circulatory and Respiratory Physiological Phenomena::Blood Physiological Phenomena::Blood Physiological Processes::Hemostasis::Blood Coagulation #Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Sepsis::Shock, Septic #Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzyme Precursors::Protein C #Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans #Medical Subject Headings::Named Groups::Persons::Age Groups::Adult
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/published

Meeting Abstract